The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 347:1619-1622 November 14, 2002 Number 20
NextNext

Therapeutic Cloning

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Weissman, I. L.
-Related Article
 by Evers, K.
-Related Article
 by Annas, G. J.
-PubMed Citation
To the Editor: In the May 16 issue, three articles deal with public policy on stem-cell research.1,2,3 The authors of all three articles agree that reproductive cloning should be banned but that research on therapeutic cloning (i.e., nuclear transplantation to produce human embryos as sources of stem cells) should be permitted. Annas justifies this compromise politically as the only way to avoid the dangers of unrestrained research.1 Evers thinks that abuses could be prevented if European and other models of regulation were globalized.2 Weissman suggests that scientists are best qualified to make informed decisions on the matter because of their . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.